RFK Jr.: Moderna Contract Canceled, COVID Policy Shift
- The Department of Health and Human Services (HHS) has canceled a contract with Moderna worth nearly $600 million.
- The cancellation of this flu pandemic vaccine contract raises concerns about the nation's preparedness for future influenza pandemics.
- the implications of this decision for future pandemic preparedness efforts remain to be seen.
HHS scrapped a $600 million contract with Moderna for flu vaccine advancement,sparking worries about future pandemic preparedness. This move, which halted work on vaccines for potential pandemic strains like H5N1 bird flu, could significantly affect strategies against emerging influenza threats. The cancellation raises critical questions: Will the U.S. be ready? What are the option plans to tackle future influenza outbreaks? News Directory 3 investigated the details of this decision, providing insights into the implications for vaccine development and the nation’s readiness. Discover what’s next …
HHS Cancels Moderna Flu Vaccine Contract Amid Pandemic Preparedness Concerns
Updated May 29, 2025
The Department of Health and Human Services (HHS) has canceled a contract with Moderna worth nearly $600 million. The agreement was intended to facilitate the development, testing, and licensing of vaccines targeting influenza strains with pandemic potential, including the H5N1 bird flu virus.
The cancellation of this flu pandemic vaccine contract raises concerns about the nation’s preparedness for future influenza pandemics. The collaboration with Moderna was seen as a crucial step in proactively addressing potential threats.
What’s next
the implications of this decision for future pandemic preparedness efforts remain to be seen. Further analysis is needed to understand how this cancellation will affect the overall strategy for combating emerging flu threats and vaccine development.
